Detailed information for compound 560165

Basic information

Technical information
  • TDR Targets ID: 560165
  • Name: sodium ethanethioate
  • MW: 101.123 | Formula: C2H6NaOS
  • H donors: 0 H acceptors: 1 LogP: 0.3 Rotable bonds: 0
    Rule of 5 violations (Lipinski): 1
  • SMILES: [SH2-]C(=O)C.[NaH+]
  • InChi: 1S/C2H4OS.Na/c1-2(3)4;/h1H3,(H,3,4);/q;+1/p-1
  • InChiKey: RBBWNXJFTBCLKT-UHFFFAOYSA-M  

Network

Hover on a compound node to display the structore

Synonyms

  • sodium thioacetate
  • 34832-35-4
  • ACETIC ACID, THIO-, SODIUM SALT
  • Ethanethioic acid, sodium salt
  • S-Sodium thioacetate
  • Sodium thiolacetate
  • Thioacetic acid sodium salt

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi RNA binding protein 0.0062 0.6747 0.6747
Schistosoma mansoni tar DNA-binding protein 0.0062 0.6747 0.4398
Echinococcus multilocularis Bcl 2 ous antagonist:killer 0.0084 1 1
Schistosoma mansoni bcl-2 homologous antagonist/killer (bak) 0.0084 1 1
Loa Loa (eye worm) apoptosis regulator protein 0.0084 1 1
Echinococcus granulosus tar DNA binding protein 0.0062 0.6747 0.4398
Brugia malayi hypothetical protein 0.0025 0.1342 0.1342
Schistosoma mansoni tar DNA-binding protein 0.0062 0.6747 0.4398
Schistosoma mansoni apoptosis regulator bax 0.0084 1 1
Trypanosoma cruzi PAB1-binding protein , putative 0.0025 0.1342 0.5
Echinococcus multilocularis EGFP:Bcl2 fusion protein 0.0084 1 1
Loa Loa (eye worm) hypothetical protein 0.0084 1 1
Echinococcus granulosus Bcl 2 ous antagonist:killer 0.0084 1 1
Schistosoma mansoni hypothetical protein 0.0084 1 1
Brugia malayi RNA recognition motif domain containing protein 0.0062 0.6747 0.6747
Schistosoma mansoni tar DNA-binding protein 0.0062 0.6747 0.4398
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0045 0.4192 0.3292
Loa Loa (eye worm) TAR-binding protein 0.0062 0.6747 0.6242
Plasmodium falciparum ataxin-2 like protein, putative 0.0025 0.1342 0.5
Echinococcus granulosus EGFP:Bcl2 fusion protein 0.0084 1 1
Plasmodium falciparum ataxin-2 like protein, putative 0.0025 0.1342 0.5
Schistosoma mansoni tar DNA-binding protein 0.0062 0.6747 0.4398
Leishmania major hypothetical protein, conserved 0.0025 0.1342 0.5
Schistosoma mansoni hypothetical protein 0.0084 1 1
Trypanosoma cruzi PAB1-binding protein , putative 0.0025 0.1342 0.5
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0045 0.4192 0.4192
Plasmodium vivax ataxin-2 like protein, putative 0.0025 0.1342 0.5
Toxoplasma gondii LsmAD domain-containing protein 0.0025 0.1342 0.5
Schistosoma mansoni tar DNA-binding protein 0.0062 0.6747 0.4398
Loa Loa (eye worm) RNA binding protein 0.0062 0.6747 0.6242
Echinococcus multilocularis tar DNA binding protein 0.0062 0.6747 0.4398
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0062 0.6747 0.6242
Trypanosoma brucei PAB1-binding protein , putative 0.0025 0.1342 0.5
Schistosoma mansoni hypothetical protein 0.0084 1 1
Brugia malayi TAR-binding protein 0.0062 0.6747 0.6747

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.